Furthermore, by analysis of the Chip-Seq data of Sp1 and Ets1 and TCGA colon cancer project data, where the 4971 genes with significant differences in expression at the primary site compared to normal tissues, 429 genes were identified as significantly different in expression levels (Figure 7C). This evidence concerns the gene ETS1 and malignant colon neoplasm.